Eastwood Bio-Medical Canada Inc. (EBM.V)

CAD 0.65

(-7.14%)

Market Cap (In CAD)

44.77 Million

Revenue (In CAD)

867.93 Thousand

Net Income (In CAD)

-546.59 Thousand

Avg. Volume

1685.00

Currency
CAD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
0.28-1.15
PE
-
EPS
-
Beta Value
0.277
ISIN
CA27783W1059
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Food Distribution
CEO
Dr. Youngsoo Kim
Employee Count
-
Website
https://www.eleotin.ca
Ipo Date
2018-08-23
Details
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.